Las Vegas, NV, June 15, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Hestia Insight Inc. (HSTA) (“Hestia Insight” and the “Company”)a company focused on developing new technologies in the healthcare and biotechnology sectors, and providing sales and marketing advice and capital markets advisory services to its clients, announced today that it had engaged PK International Inc., a Taiwanese company, as its exclusive sales and marketing agent partner to expand the Company’s presence in Asia.

“After the disastrous global impact of COVID-19, we are reinvigorating our efforts to reach Asian companies seeking access to U.S. public markets,” said Edward C. Lee, the company’s president and CEO.

Additionally, the company employs a mergers and acquisitions strategy and brings together a highly experienced team, including senior executives, an independent director, corporate and securities counsel and seasoned consultants, to scout and identify potential candidates. potential for merger and acquisition. Hestia Insight is particularly interested in companies in the health, wellness and nutrition sectors, including healthy foods and supplements, health technologies and healthcare.

Mr. Lee explained, “We believe Hestia Insight can add significant value and experience to established, revenue-generating companies with positive cash flows looking to access US capital markets and grow their operations through Mergers and Acquisitions.

About Hestia Insight Inc.

Hestia Insight Inc. (“Hestia Insight” and the “Company”) focuses primarily on the healthcare and biotechnology sectors through the Company’s two wholly-owned subsidiaries, Hestia Investments Inc. (“Hestia Investments ”) and HSTA Health Inc. (“HSTA Health”). Hestia Investments provides strategic advice, medical supply sales and marketing support, management and financial market advisory services for select micro, small and medium enterprises in the healthcare and biotechnology sectors. HSTA Health provides healthcare management and patient services and develops new healthcare technologies for neurological and psychiatric disorders. The Company is positioned to make strategic acquisitions of emerging growth companies with unique science and technology. The Company intends to pursue the acquisition and development of healthcare-related technologies in the healthcare and biotechnology sectors through acquisitions, licenses or joint ventures. The Company will also consider a third avenue of investment in certain technologies. The Company has entered the healthcare industry to explore emerging healthcare technologies, especially growing companies that own and develop unique science and technology.

For more information about Hestia Insight, please visit the company’s website:

Hestia Insight Investor Relations:

Facebook: Hestia Insight Inc.

LinkedIn: Hestia Insight Inc.

Twitter: @HestiaInsight

Hestia Insight is subject to the disclosure and reporting requirements of the Securities Exchange Act of 1934, as amended, and pursuant to the Securities Exchange Act, the Company files periodic reports, documents and other information with the SEC regarding our business, financial statements and other matters. These documents are made available to the public on the Commission’s website at

Safe Harbor Layout

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, which are intended to be covered by the safe harbor thus created.All statements other than statements of historical fact contained herein, including, without limitation, statements regarding the Company’s future financial condition, business strategy, plans and objectives, growth and profitability, its growth strategy, its liquidity and its access to public markets, the reduction of operating expenses and trends in the industry in which the Company operates, are forward-looking statements. Forward-looking statements can generally be identified by the use of forward-looking words such as “may”, “will”, “expect”, “intend”, “plan”, “project”, “estimate”. , “anticipates”, or “believes” or the negative thereof or any variation thereof or similar terminology or expressions. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those proposed in such statements. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, it cannot guarantee that these expectations will prove to be correct. Important factors that could cause actual results to differ materially from the Company’s expectations include, but are not limited to, factors set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended November 2021 and its other filings and submissions. with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, the Company assumes no obligation to update or revise any forward-looking statements.

Contact with Investor Relations:

Paul Knopick

Tel: 940.262.3584

E-mail: [email protected]


About The Author

Related Posts